Latest news
High-Dose Vitamin D3 Fails to Improve PFS in Phase 3 Metastatic CRC Trial - The American Journal of Managed CareThe American Journal of Managed Care · Thu, 06 Aug 2026 20:12:22 GMTTalazoparib and Enzalutamide Combo Shows Promise in Treating Certain Prostate Cancers - Oncology News CentralOncology News Central · Mon, 03 Aug 2026 00:00:00 GMTAtezolizumab Plus Chemotherapy Improves PFS in dMMR/MSI-H Metastatic CRC - CancerNetworkCancerNetwork · Thu, 30 Jul 2026 15:37:19 GMTRisvutatug Rezetecan Improves PFS in Phase 3 Osteosarcoma Trial - Targeted OncologyTargeted Oncology · Thu, 30 Jul 2026 07:00:00 GMT